Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000019455
JPRN-UMIN000019455
Completed
未知

Study of the Influenza vaccine immune response using PMMA dialyzer. - Influenza vaccine effectiveness in using PMMA dialyzer

Oita University Hospital Blood purification center0 sites120 target enrollmentOctober 26, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Oita University Hospital Blood purification center
Enrollment
120
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2015
End Date
May 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oita University Hospital Blood purification center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •A patient who is judged as the inadequate subject of this study by the doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study of the Influenza vaccine immune response using PMMA dialyzer.End-stage renal disease requiring hemodialysis
JPRN-UMIN000015853Oita naika clinic50
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-003055-30-ESGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-003055-30-CZGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisib
EUCTR2017-003055-30-PLGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisib
EUCTR2017-003055-30-FRGilead Sciences, Inc.22